Intralipid (Page 3 of 3)


Intralipid ® 10% is supplied as a sterile emulsion in the following fill sizes: 100 mL, 250 mL, and 500 mL.

100 mL: 0338-0518-58
250 mL: 0338-0518-12
500 mL: 0338-0518-13


Intralipid ® 10% should not be stored above 25°C (77°F). Do not freeze Intralipid ® 10%. If accidentally frozen, discard the bag.


  1. Padley FB: “Major Vegetable Fats,” The Lipid Handbook (Gunstone FD, Harwood JL, Padley FB, eds.), Chapman and Hall Ltd., Cambridge, UK (1986), pp. 88-9.
  2. Levene MI, Wigglesworth JS, Desai R: Pulmonary fat accumulation after Intralipid ® infusion in the preterm infant. Lancet 1980; 2(8199):815-8.
  3. American Academy of Pediatrics: Use of intravenous fat emulsion in pediatric patients. Pediatrics 1981; 68:5 (Nov) 738-43.

(Rev Septemer 2016)

Manufactured for
Baxter Healthcare Corporation
Deerfield, IL 60015 USA

Manufactured by
Fresenius Kabi,
Uppsala, Sweden

Intralipid ® is a registered trademark of Fresenius Kabi AB.

Instructions for Use — Intralipid ® 10% Container

figure 1
(click image for full-size original)
image 2
(click image for full-size original)
image 3
(click image for full-size original)
figure 4
(click image for full-size original)
image 5
(click image for full-size original)

figure 6
(click image for full-size original)

figure 1image 2image 3figure 4image 5figure 6

PACKAGE LABEL — PRINCIPAL DISPLAY — Intralipid 250 mL Container Label

NDC 0338-0518-12

Intralipid ® 1 0%

A 10% I.V. Fat Emulsion

250 mL For Intravenous Use

Rx only

bag 10
(click image for full-size original)
INTRALIPID i.v. fat emulsion emulsion
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0338-0518
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Inactive Ingredients
Ingredient Name Strength
# Item Code Package Description Multilevel Packaging
1 NDC:0338-0518-58 100 mL in 1 BAG None
2 NDC:0338-0518-12 250 mL in 1 BAG None
3 NDC:0338-0518-13 500 mL in 1 BAG None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017643 12/12/2014
Labeler — Baxter Healthcare CORP (005083209)
Registrant — Fresenius Kabi Deutschland GmbH (506719546)
Name Address ID/FEI Operations
Fresenius Kabi AB Uppsala 559785113 analysis (0338-0518), manufacture (0338-0518)

Revised: 01/2019 Baxter Healthcare CORP

Page 3 of 3 1 2 3

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.